| Joelle Ione Black, MPAS, PA-C | |
|
2401 S 31st St, Temple, TX 76508-0001 | |
| (254) 724-2111 | |
| (254) 724-7603 |
| Full Name | Joelle Ione Black |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 13 Years |
| Location | 2401 S 31st St, Temple, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104196534 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | PA13949 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baylor Scott & White Pavilion - Temple | Temple, TX | Hospital |
| Baylor Scott & White Medical Center - Round Rock | Round rock, TX | Hospital |
| Baylor Scott & White Medical Center- College Stati | College station, TX | Hospital |
| Baylor Scott & White Medical Center Buda | Buda, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Scott And White Clinic | 8123923604 | 2131 |
News Archive
New vaccinations to prevent infections that lead to cervical cancer and targeted therapeutics aimed at breast cancer were examples of research highlights presented by scientists today at the 95th Annual Meeting of the American Association for Cancer Research. Scientists described advances that feed into the drug development 'pipeline,' and show strong promise for controlling existing tumors or addressing the pathogen that causes tumors.
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced updated long-term data from a Phase I clinical trial of ICT-107, the Company's lead cancer vaccine candidate for the treatment of glioblastoma multiforme, the most common and aggressive form of brain cancer.
TearScience, Inc., a privately-held medical device company, today announced that it has received U.S. Food and Drug Administration (FDA) clearance for its next generation product of its LipiFlow Thermal Pulsation System, a medical device that treats evaporative dry eye by liquefying and evacuating obstructions in meibomian glands located in the eyelids.
Other such pathways - known as surveillance pathways - operate in a more general way, in many cell types. Knowing how this specific surveillance system works can help researchers better understand hereditary diseases, in this case, thalassemia, a form of anemia, which is the most common genetic disorder worldwide.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joelle Ione Black, MPAS, PA-C Po Box 844658, Dallas, TX 75284-4658 Ph: () - | Joelle Ione Black, MPAS, PA-C 2401 S 31st St, Temple, TX 76508-0001 Ph: (254) 724-2111 |
News Archive
New vaccinations to prevent infections that lead to cervical cancer and targeted therapeutics aimed at breast cancer were examples of research highlights presented by scientists today at the 95th Annual Meeting of the American Association for Cancer Research. Scientists described advances that feed into the drug development 'pipeline,' and show strong promise for controlling existing tumors or addressing the pathogen that causes tumors.
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced updated long-term data from a Phase I clinical trial of ICT-107, the Company's lead cancer vaccine candidate for the treatment of glioblastoma multiforme, the most common and aggressive form of brain cancer.
TearScience, Inc., a privately-held medical device company, today announced that it has received U.S. Food and Drug Administration (FDA) clearance for its next generation product of its LipiFlow Thermal Pulsation System, a medical device that treats evaporative dry eye by liquefying and evacuating obstructions in meibomian glands located in the eyelids.
Other such pathways - known as surveillance pathways - operate in a more general way, in many cell types. Knowing how this specific surveillance system works can help researchers better understand hereditary diseases, in this case, thalassemia, a form of anemia, which is the most common genetic disorder worldwide.
› Verified 5 days ago
Christina Esmat Karimi, P.A Physician Assistant Medicare: Medicare Enrolled Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 | |
Mark Brooks, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 | |
Krysten Berry Longoria, P.A. Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 2401 S. 31st Street, Temple, TX 76508 Phone: 254-724-0454 | |
Mrs. Kara Madison Rafuse Marcum, Physician Assistant Medicare: Medicare Enrolled Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 832-385-4937 | |
Lauren Joyce Chiang, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 7556 Honeysuckle, Temple, TX 76502 Phone: 254-742-7400 | |
Yordanos Haile Tesfaye, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 | |
Matthew R. Hoffman, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1901 Veterans Memorial Dr, Temple, TX 76504 Phone: 254-778-4811 |